Globe Life (NYSE:GL) is an insurance holding company. It provides life insurance and supplemental health insurance products primarily to middle and lower-middle-income households in the United States. The company operates through various subsidiaries to serve both individual insurance and group insurance markets, solidifying its position in the broader insurance industry.
On April 22, 2026, Globe Life reported its first-quarter financial results. The company announced an earnings per share (EPS) of $3.43, which fell just short of the analyst consensus estimate of $3.46. Revenue for the quarter was approximately $1.56 billion, also slightly missing the estimated $1.564 billion. These figures are crucial for comprehensive investor analysis.
Despite missing analyst estimates, the results show strong year-over-year growth. As reported by PR Newswire, net operating income increased to $3.43 per share, up from $3.07 in the same quarter of 2025. This indicates an improvement in the company's core profitability and overall financial performance compared to the previous year.
From a valuation standpoint, Globe Life has a Price-to-Earnings (P/E) ratio of 10.61. This key valuation metric measures the company's current share price relative to its per-share earnings. Additionally, the company's Price-to-Sales ratio is 1.96, and it offers an earnings yield of 9.42%, providing valuable market insights for potential investors.
The company's financial health appears stable. It maintains a debt-to-equity ratio of 0.44, which shows that its assets are funded more by equity than by debt, indicating a conservative capital structure. Furthermore, Globe Life has a strong current ratio of 9.66, indicating it has sufficient short-term assets to cover its short-term liabilities, reinforcing its solvency and operational stability.
